Table A2.
Adverse Event | Grade 1 |
Grade 2 |
Grade 3 |
Grade 4 |
||||
---|---|---|---|---|---|---|---|---|
No. of Patients | % | No. of Patients | % | No. of Patients | % | No. of Patients | % | |
Hematologic toxicities | ||||||||
Anemia | 8 | 42.1 | 1 | 5.3 | ||||
Leukopenia | 5 | 26.3 | 1 | 5.3 | ||||
Neutropenia | 4 | 21.1 | 1 | 5.3 | ||||
Lymphopenia | 5 | 26.3 | 1 | 5.3 | ||||
Nonhematologic toxicities | ||||||||
General | ||||||||
Anxiety | 1 | 5.3 | ||||||
Fatigue | 3 | 15.8 | ||||||
Fever | 1 | 5.3 | ||||||
Hot flashes | 2 | 10.5 | ||||||
Flu-like symptoms | 1 | 5.3 | ||||||
Muscle weakness | 1 | 5.3 | 1 | 5.3 | ||||
HEENT | ||||||||
Watery eye | 1 | 5.3 | ||||||
Rhinorrhea | 2 | 10.5 | ||||||
GI | ||||||||
Dry mouth | 1 | 5.3 | ||||||
Nausea/vomiting | 5 | 26.3 | 1 | 5.3 | ||||
Diarrhea | 1 | 5.3 | ||||||
Constipation | 1 | 5.3 | ||||||
Cardiac | ||||||||
Hypotension | 1 | 5.3 | ||||||
Paroxysmal tachycardia | 1 | 5.3 | ||||||
Respiratory | ||||||||
Cough | 5 | 26.3 | ||||||
Upper respiratory tract infection | 1 | 5.3 | ||||||
Wheezing | 1 | 5.3 | ||||||
Pain | ||||||||
Abdominal | 2 | 10.5 | ||||||
Back | 2 | 10.5 | 1 | 5.3 | ||||
Bone | 1 | 5.3 | ||||||
Chest | 1 | 5.3 | ||||||
Extremity | 1 | 5.3 | ||||||
Neck | 1 | 5.3 | ||||||
Pain NOS | 2 | 10.5 | ||||||
Throat | 1 | 5.3 | ||||||
Tumor site | 1 | 5.3 | 1 | 5.3 | ||||
CNS | ||||||||
Headache | 2 | 10.5 | ||||||
Intracranial hemorrhage | 1 | 5.3 | ||||||
Seizure | 2 | 10.5 | ||||||
Numbness | 1 | 5.3 | ||||||
Musculoskeletal | ||||||||
Bruising | 1 | 5.3 | ||||||
Ankle fracture | 1 | 5.3 | ||||||
Laboratory | ||||||||
ALT | 3 | 15.8 | ||||||
Alkaline phosphatase | 3 | 15.8 | 2 | 10.5 | ||||
AST | 6 | 31.6 | ||||||
Hyperglycemia | 2 | 10.5 | ||||||
Hyperkalemia | 1 | 5.3 | 1 | 5.3 | ||||
Hypernatremia | 2 | 10.5 | ||||||
Hypoalbuminemia | 1 | 5.3 | ||||||
Hypocalcemia | 2 | 10.5 | ||||||
Hypokalemia | 5 | 26.3 | ||||||
Hyponatremia | 3 | 15.8 |
Abbreviations: CAR, chimeric antigen receptor; HEENT, head, eyes, ears, nose, and throat; HER2, human epidermal growth factor receptor 2; NOS, not otherwise specified.